Credit Suisse’s Rhythm Pharmaceuticals RYTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
$1.87M Buy
43,164
+1,152
+3% +$49.9K ﹤0.01% 1896
2023
Q4
$1.93M Sell
42,012
-1,306
-3% -$60K ﹤0.01% 1902
2023
Q3
$993K Sell
43,318
-25,683
-37% -$589K ﹤0.01% 2302
2023
Q2
$1.14M Buy
69,001
+13,710
+25% +$226K ﹤0.01% 2282
2023
Q1
$986K Buy
55,291
+7,879
+17% +$141K ﹤0.01% 2323
2022
Q4
$1.38M Buy
47,412
+11,928
+34% +$347K ﹤0.01% 2103
2022
Q3
$869K Buy
35,484
+10,962
+45% +$268K ﹤0.01% 2413
2022
Q2
$102K Sell
24,522
-2,749
-10% -$11.4K ﹤0.01% 3507
2022
Q1
$314K Sell
27,271
-1,146
-4% -$13.2K ﹤0.01% 3187
2021
Q4
$283K Buy
28,417
+2,837
+11% +$28.3K ﹤0.01% 3317
2021
Q3
$335K Buy
25,580
+1,778
+7% +$23.3K ﹤0.01% 3214
2021
Q2
$467K Sell
23,802
-1,654
-6% -$32.5K ﹤0.01% 3064
2021
Q1
$541K Sell
25,456
-18,820
-43% -$400K ﹤0.01% 2905
2020
Q4
$1.32M Buy
44,276
+27,216
+160% +$810K ﹤0.01% 2391
2020
Q3
$369K Sell
17,060
-19,993
-54% -$432K ﹤0.01% 2812
2020
Q2
$826K Buy
37,053
+22,915
+162% +$511K ﹤0.01% 2407
2020
Q1
$215K Sell
14,138
-1,014
-7% -$15.4K ﹤0.01% 3005
2019
Q4
$347K Buy
15,152
+3,846
+34% +$88.1K ﹤0.01% 3101
2019
Q3
$244K Sell
11,306
-2,877
-20% -$62.1K ﹤0.01% 3125
2019
Q2
$311K Buy
14,183
+4,648
+49% +$102K ﹤0.01% 3027
2019
Q1
$261K Buy
9,535
+855
+10% +$23.4K ﹤0.01% 3074
2018
Q4
$233K Sell
8,680
-7,270
-46% -$195K ﹤0.01% 3086
2018
Q3
$466K Buy
15,950
+7,154
+81% +$209K ﹤0.01% 2883
2018
Q2
$275K Buy
+8,796
New +$275K ﹤0.01% 3195